Factors | N | CD4 < 200 (%) | OR (95% CI) | p | AOR (95%CI) | p | |
---|---|---|---|---|---|---|---|
Total | 6530 | 837 | 12.8% | ||||
Model 1 | |||||||
 VL 50–999 and No DR | 1636 | 195 | 11.9% | 1.0 |  | 1.0 |  |
 VL 50–999 and DR | 182 | 58 | 31.9% | 3.5 (2.4, 4.9) | < 0.01 | 3.8 (2.6, 5.5) | < 0.01 |
 VL < 50 | 3787 | 244 | 6.4% | 0.5 (0.4, 0.6) | < 0.01 | 0.5 (0.4, 0.6) | < 0.01 |
 VL ≥ 1000 and No DR | 430 | 130 | 30.2% | 3.2 (2.5, 4.1) | < 0.01 | 3.1 (2.4, 4.1) | < 0.01 |
 VL ≥ 1000 and DR | 495 | 210 | 42.4% | 5.4 (4.3, 6.9) | < 0.01 | 5.8 (4.5, 7.4) | < 0.01 |
Model 2 | |||||||
 VL 50–200 and No DR | 537 | 38 | 7.1% | 1.0 |  | 1.0 |  |
 VL 201–999 and No DR | 1099 | 157 | 14.3% | 2.2 (1.5, 3.2) | 0.14 | 2.4 (1.6, 3.6) | 0.34 |
 VL 50–200 and DR | 23 | 2 | 8.7% | 1.3 (0.3, 5.5) | 0.23 | 1.2 (0.3, 5.6) | 0.21 |
 VL 201–999 and DR | 159 | 56 | 35.2% | 7.1 (4.5, 11.3) | < 0.01 | 8.0 (4.9, 13.1) | < 0.01 |
 VL < 50 | 3787 | 244 | 6.4% | 0.9 (0.6, 1.3) | < 0.01 | 0.9 (0.6, 1.2) | < 0.01 |
 VL ≥ 1000 and No DR | 430 | 130 | 30.2% | 5.7 (3.9, 8.4) | < 0.01 | 5.7 (3.8, 8.5) | < 0.01 |
 VL ≥ 1000 and DR | 495 | 210 | 42.4% | 9.7 (6.7, 14.1) | < 0.01 | 10.7 (7.2, 15.9) | < 0.01 |